Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?

(2014) Hashem B. El-Serag et al.   HEPATOLOGY

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma

(2014) Alessandro Cucchetti et al.   JOURNAL OF HEPATOLOGY

Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults

(2014) Krishnan Bhaskaran et al.   LANCET

Global alcohol exposure estimates by country, territory and region for 2005-a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study

(2013) Kevin D. Shield et al.   ADDICTION

From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights

(2013) Samuele De Minicis et al.   CURRENT PHARMACEUTICAL DESIGN

Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma

(2013) Luigi Bolondi et al.   DIGESTIVE AND LIVER DISEASE

Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization

(2013) Eun Sun Jang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

From NAFLD in clinical practice to answers from guidelines

(2013) Fabio Nascimbeni et al.   JOURNAL OF HEPATOLOGY

Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres

(2013) Nora Cazzagon et al.   LIVER INTERNATIONAL

Diffuse Infiltrative Hepatocellular Carcinoma: Assessment of Presentation, Treatment, and Outcomes

(2012) Peter J. Kneuertz et al.   ANNALS OF SURGICAL ONCOLOGY

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace

(2012) György Baffy et al.   JOURNAL OF HEPATOLOGY

HCC and NASH: How strong is the clinical demonstration?

(2012) O. Rosmorduc et al.   Clinics and Research in Hepatology and Gastroenterology

Epidemiology and Surveillance of Hepatocellular Carcinoma

(2012) Do Young Kim et al.   Liver Cancer

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma

(2011) Kohichiroh Yasui et al.   Clinical Gastroenterology and Hepatology

Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease

(2011) Srinevas K. Reddy et al.   HEPATOLOGY

Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient – death of a dogma from analysis of therapeutic studies?

(2011) Amedeo Lonardo et al.   Expert Review of Gastroenterology & Hepatology

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis

(2009) Valérie Paradis et al.   HEPATOLOGY